Weizhi Xu
Xiamen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
A Prospective, Single-Center, Single-Arm, Exploratory Study of 177Lu-LNC1010 Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 07, 2026
177Lu-LNC1004 Radioligand Therapy in Patients with End-stage Metastatic Cancers: A Single-Center, Single-Arm, Phase II Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 22, 2024
FAP-targeted PET/CT imaging in patients with breast cancer from a prospective bi-center study: insights into diagnosis and clinic management.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 29, 2024
Current status of FAP-directed cancer theranostics: a bibliometric analysis.
Journal: Biophysics reports
Published: June 07, 2024
Occult SMARCA4-Deficient Undifferentiated Carcinoma Unmasked by 68 Ga-FAPI-46 PET/CT.
Journal: Clinical nuclear medicine
Published: March 27, 2024
Safety, dosimetry, and efficacy of an optimized long-acting somatostatin analog for peptide receptor radionuclide therapy in metastatic neuroendocrine tumors: From preclinical testing to first-in-human study.
Journal: Acta pharmaceutica Sinica. B
Published: February 28, 2024
Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade.
Journal: Signal transduction and targeted therapy
Published: October 28, 2023
Acute Appendicitis Complicated by Septic Thrombophlebitis of the Portal Vein Shown by 18 F-FDG and 68 Ga-FAPI-46 PET/CT.
Journal: Clinical nuclear medicine
Published: October 05, 2023
Superior Identification of Metastatic Lesions by 68 Ga-FAPI-46 to 18 F-FDG PET/CT in a Case of SMARCA4-Deficient Undifferentiated Carcinoma of Stomach.
Journal: Clinical nuclear medicine
Published: September 13, 2023
Evaluation of FAPI PET imaging in gastric cancer: a systematic review and meta-analysis.
Journal: Theranostics
Published: July 21, 2023
SSTR antagonist [68Ga]Ga-DOTA-LM3 differentiates intrapancreatic accessory spleen from neuroendocrine tumor in a patient presenting indeterminate MRI and SSTR agonist [68Ga]Ga-DOTATATE.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 14, 2023
Fibroblast Activation Protein-Targeted PET/CT with 18F-Fibroblast Activation Protein Inhibitor-74 for Evaluation of Gastrointestinal Cancer: Comparison with 18F-FDG PET/CT.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 12, 2023
Last Updated: 09/26/2026